0001610717-24-000040.txt : 20240124 0001610717-24-000040.hdr.sgml : 20240124 20240124161233 ACCESSION NUMBER: 0001610717-24-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240122 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cislini Jeff CENTRAL INDEX KEY: 0001969082 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 24556534 MAIL ADDRESS: STREET 1: C/O REVOLUTION MEDICINES, INC. STREET 2: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 form4.xml X0508 4 2024-01-22 0001628171 Revolution Medicines, Inc. RVMD 0001969082 Cislini Jeff C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063 true General Counsel true Common Stock 2024-01-22 4 S 0 1500 27 D 36126 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023. Includes 31,417 restricted stock units. Includes 342 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023. /s/ Jack Anders, as Attorney-in-fact for Jeff Cislini 2024-01-24